Denis Delaney

Denis Delaney has worked for three companies in the pharmaceutical industry, beginning with EirGen Pharma in 2014. There, they held the role of Formulation Development Team Lead. In 2018, they moved to Teva Pharmaceuticals, where they became Manager Pharmaceutical Development. Most recently, in 2021, they joined Shorla Oncology as Head of Research And Development and Research And Development Manager.

Denis Delaney completed an MSc in Pharmaceutical Regulatory Affairs at the Institute of Technology, Carlow in 2018. Prior to that, they obtained a BSc (Hons) in Applied Chemistry with TQM from the Waterford Institute of Technology in 2007.